CIE-10

CIE-10-código M72

You are here: Inicio > CIE-10 > M00-M99 > M60-M79 > M70-M79

- CIE-10
Clasificación Internacional de Enfermedades
- M00-M99
Enfermedades del sistema osteomuscular y del tejido conjuntivo
- M60-M79
Trastornos de los tejidos blandos
- M70-M79
Otros trastornos de los tejidos blandos

M72

Trastornos fibroblásticos

CIE-10 Сódigo M72 para Trastornos fibroblásticos

[Para el código de sitio ver las subclasificaciones antes de M00–M25]

Excluye: fibromatosis retroperitoneal (D48.3)

M72.0
Fibromatosis de la aponeurosis palmar [Dupuytren]
M72.1
Nódulos interfalángicos
M72.2
Fibromatosis de la aponeurosis plantar
M72.4
Fibromatosis seudosarcomatosa
M72.6
Fascitis necrotizante
M72.8
Otros trastornos fibroblásticos
M72.9
Trastorno fibroblástico, no especificado
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us